Skip to search formSkip to main contentSkip to account menu

IDO2 gene

Known as: INDOLEAMINE-PYRROLE 2,3-DIOXYGENASE-LIKE 1, INDOL1, IDO2 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Improved Estimation of Total Blood Volume Can Provide a Reliable Prediction of Dilutional Hematocrit and Oxygen Delivery during Cardiopulmonary Bypass.
Optimal oxygen delivery during cardiopulmonary bypass (CPB) for open heart surgery is crucial to protect organ function, improve… 
2018
2018
Genome-wide analysis of psychotic-like experiences
This study aimed to test for overlap in genetic influences between psychotic-like experience traits shown by adolescents in the… 
2017
2017
An endogenous ligand of the human aryl hydrocarbon receptor promotes tumor formation
Activation of the aryl hydrocarbon receptor (AHR) by environmental xenobiotic toxic chemicals, for instance 2,3,7,8… 
Review
2017
Review
2017
IDO 2 in Immunomodulation and Autoimmune Disease
Part of the Medical Microbiology Commons This Article is brought to you for free and open access by the Jefferson Digital Commons… 
2016
2016
Deletion of TDO 2 , IDO-1 and IDO-2 differentially affects mouse behavior and cognitive function
2014
2014
AHR: A Temple of Tolerance to Toxemia
Signaling via the aryl hydrocarbon receptor minimizes the detrimental effects of infection without compromising the immune… 
Review
2013
Review
2013
Inflammatory programming and immune modulation in cancer by IDO
Immune dysregulation is one of the hallmarks of tumor growth and progression, a key event that allows for tumor evasion of the… 
2011
2011
IDO1 and IDO2 gene expression analysis by quantitative polymerase chain reaction.
Immunomodulatory properties of IDO1 relate to tryptophan catabolism. The degradation of tryptophan by IDO1 leads to suppression… 
2010
2010
660 Discovery of a novel series of indoleamine 2,3-dioxygenase 2 (IDO2) selective inhibitors for probing IDO2 function in cancer
2009
2009
Impact of the IDO2 blocker D-1-methyltryptophan on the IDO activity of human tumors and dendritic cells
Clinical phase-I-trials with cancer patients have been started with the aim of inducing tumor immunity by blocking the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)